ABSTRACT Objectives To validate the previously proposed classifi cation criteria for Henoch-Schönlein purpura (HSP), childhood polyarteritis nodosa (c-PAN), c-Wegener granulomatosis (c-WG) and c-Takayasu arteritis (c-TA).
INTRODUCTION
In 1990 the American College of Rheumatology (ACR) proposed classifi cation criteria for patients with vasculitides [1] [2] [3] [4] [5] by analysing 807 adults patients with different form of vasculitis: 85 with Henoch-Schönlein purpura (HSP), 118 with polyarteritis nodosa (PAN), 85 with Wegener granulomatosis (WG), 63 with Takayasu arteritis (TA) and 456 with other vasculitides (Churg-Strauss, hypersensitivity, giant cell arteritis and other unspecifi ed forms). 6 Patients with each specifi c vasculitis were compared with all the remaining diseases grouped into a single control category.
The ACR criteria for HSP (sensitivity 87.1%, specifi city 87.7%) require the presence of at least two of the following: (1) age ≤20 years at disease onset; (2) palpable purpura; (3) acute abdominal pain; (4) biopsy showing granulocytes in the walls of small arterioles/venules. 1 The ACR criteria for PAN (sensitivity 82.2%, specifi city 86.6%) require at least three of the 10 following criteria: (1) granulocyte or mixed leucocyte infi ltrate in an arterial wall on biopsy; (2) arteriographic abnormalities; (3) livedo reticularis; (4) myalgia; (5) diastolic blood pressure (BP) >90 mm Hg; (6) mono-or polyneuropathy; (7) elevated blood urea nitrogen or creatinine; (8) testicular pain/tenderness; (9) hepatitis B reactants; (10) weight loss >4 kg. 3 5 The ACR criteria for WG (sensitivity 88.2%, specifi city 92%) require at least two of the following: (1) abnormal urinary sediment (red cell casts or >5 red blood cells per high power fi eld); (2) abnormal fi ndings on chest radiograph (nodules, cavities or fi xed infi ltrates); (3) oral ulcers or nasal discharge; (4) granulomatous infl ammation on biopsy. 4 Finally, the ACR criteria for TA (sensitivity of 91%, specifi city 98%) require the presence of at least three of the following: (1) arteriographic evidence of narrowing or occlusion of the entire aorta, its primary branches, or large arteries in the proximal, upper or lower extremities; (2) decreased brachial artery pulse; (3) claudication of an extremity; (4) systolic BP >10 mm Hg difference in systolic BP between arms; (5) a bruit over subclavian arteries or the aorta; (6) age at disease onset ≤40 years. 2 The ACR criteria were derived by comparing 63 patients with adult TA with 744 controls with other vasculitides.
In 2005 the vasculitis working group of the Paediatric Rheumatology European Society (PRES) proposed new classifi cation criteria for paediatric vasculitides, endorsed by the European League Against Rheumatism (EULAR). 7 However, these proposed modifi cations were mainly based on a literature review and a consensus-based process and were not formally validated. Thanks to support from EULAR, the Paediatric Rheumatology International Trials Organisation (PRINTO) 8 and PRES, a formal statistical validation process, with a large-scale, web-based data collection, was undertaken. The project culminated fi nally at the 2008 Ankara Consensus Conference which had, as its primary objective, the validation of the aforementioned EULAR-endorsed criteria for paediatric vasculitides.
With this second paper we describe the fi nal classifi cation criteria for each of the four vasculitides analysed (HSP, c-TA, c-PAN and c-WG) while the general methodology and overall demographic and clinical characterisation are reported in the accompanying paper. 9 
PATIENTS AND METHODS
The methodology used is described in detail in the accompanying introduction and methods paper. 9 In brief, after obtaining consent from parent(s)/child and ethics committee approval as appropriate, 97 PRINTO/PRES institutions in 36 countries, enrolled children with vasculitides, into a three-step retrospective/prospective study.
Step 1: Web-based data collection
Children with age at diagnosis ≤18 years, diagnosed by their treating physician, as HSP, c-PAN, c-WG, c-TA or other c-primary systemic vasculitis (c-other) were included. Data collected included demographic, diagnosis, signs/symptoms (glossary provided) before/or at the date of diagnosis and at least 3 months after, laboratory, histopathological and imaging reports.
Step 2: Classifi cation by consensus panel Using three Delphi technique 10 web-rounds, a subgroup of 280 cases were classifi ed (blinded to original diagnosis by the treating physician), by a panel of 11 paediatric rheumatologists/ nephrologists into HSP, c-PAN, c-WG, c-TA or c-other. The main purpose of the classifi cation exercise was to evaluate the κ level of agreement 11 12 with 95% CI between the consensus panel classifi cation and the attending physician diagnosis.
Step 3: Statistical and consensus evaluations
A nominal group technique 10 consensus conference was convened in Ankara in October 2008 to discuss the statistical performance (frequency, sensitivity, specifi city, area under the curve (AUC) and κ) of clinical/laboratory fi ndings (criteria) and of 56 HSP, 29 c-PAN, 62 c-WG and 25 c-TA defi nitions. For the purposes of the statistical analysis all cases of specifi c vasculitis (eg, HSP classifi ed by the consensus panel or diagnosed by the treating physician) were compared with the control group represented by the remaining cases of childhood vasculitides (eg, c-PAN, c-WG, c-TA, c-other).
RESULTS
Of the 1398 children enrolled, 860 (62%) were diagnosed by the treating physician as HSP, 172 (12%) as c-PAN, 67 (5%) as c-WG, 99 (7%) as c-TA and 200 (14%) as c-other.
Henoch-Schönlein purpura
Step 1: Web-based data collection From the 860/1398 (62%) children with HSP available in the database, 29 patients were excluded from the analysis for the following reasons: 16 patients because they were diagnosed with infantile haemorrhagic oedema/Finkelstein purpura (all aged <1 year), seven because of other co-morbid conditions and six for missing data.
Step 2: Classifi cation by consensus panel Sixty patients (22 diffi cult cases and 38 randomly selected) were blinded for the referring centre diagnosis and classifi ed by the consensus panel: 56 were confi rmed as HSP while four were excluded (in three patients consensus not achieved and one was unclassifi able). The κ-agreement between the consensus panel and treating physician was 0.96 (95% CI 0.84 to 1), therefore justifying the inclusion of all 827 patients with HSP in the next step.
Step 3: Statistical and consensus evaluations The 827/1183 (70%) patients with HSP (771 diagnosed by the treating physician and 56 by the consensus panel) were included in the fi nal analysis and compared with the remaining 356 patients with another form of vasculitides who were used as a control group (c-PAN 150, c-WG 60, c-TA 87, c-other 59 patients).
All patients had purpura (lower limb predominance or diffuse combined) while the characteristic palpable purpura, commonly in crops, with lower limb predominance was seen in 89% of the patients with HSP and in 15% of those with c-PAN and c-WG. Diffuse abdominal pain was present in 60% of children with HSP, arthritis/arthralgia in 78%, proteinuria/haematuria combined in 33%. IgA deposition was observed in 83/827 (10%) of the HSP cases but only 125 patients (89 HSP and 36 controls) had biopsies available. There were no other signs and symptoms, laboratory/ biopsy/imaging reports that were more frequently seen in patients with HSP than in the other vasculitides (see accompanying paper 9 for further details and online supplementary fi gure 1A web). Figure 1A shows the sensitivities/specifi cities of patients with HSP versus the other c-vasculitides. Purpura with lower limb predominance and IgA deposition had both sensitivities/specifi cities >80%; vessel wall granulocytes (ACR criterion) had a low specifi city (26%). Abdominal pain had sensitivities/specifi cities >60%, arthritis/arthralgia was sensitive (78%) but less specifi c and proteinuria/haematuria was specifi c (70%) but less sensitive. Table 1 provides a glossary of defi nitions, sensitivity/specifi city/AUC for each HSP criterion and the fi nal EULAR/ PRINTO/PRES defi nition. The sensitivities/specifi cities/AUC and κ-agreement (between the consensus panel and specifi c defi nition) of the fi nal HSP EULAR/PRINTO/PRES classifi cation defi nition was 100%/87%/93.5%, respectively, with an almost perfect κ-agreement of 0.90 (95% CI 0.84 to 0.96) compared with 100%/69% of the preliminary EULAR HSP proposal. The sensitivity/specifi city of the original HSP group.bmj.com on March 13, 2012 -Published by ard.bmj.com Downloaded from 45 patients with cutaneous PAN and 14 with microscopic polyangiitis were also excluded from the analysis.
Step 3: Statistical and consensus evaluations The 150/1124 (13%) patients with c-PAN (112 diagnosed by the treating physician and 38 by the consensus panel) were included in the fi nal analysis and compared with the remaining 974 patients (HSP 827, c-WG 60, 87 c-TA).
Small-or medium-sized artery necrotising vasculitis was documented in 28 (19%) and 52 (35%) patients, respectively (small or medium in 67 patients, 45%). Angiographic abnormalities were present in 64 patients (43%), with 14 (9%) having stenoses of medium/small arteries and 57 (38%) aneurysms. The presence of necrotising vasculitis or angiographic abnormalities was seen in 116 (77%) of the patients. Among the others signs/symptoms the most common was myalgia reported by 108 (72%) patients. The second clinical characteristic was skin involvement observed in 104 (69%) patients with c-PAN versus 18 (30%) with c-WG; 51 (34%) with livedo reticularis, 84 (56%) with skin nodules, 19 (13%) with superfi cial skin infarction ACR criteria were 100%/2%/51% (κ=0.04), which rose to 100%/75%/87.5% (κ=0.81) when the age criterion (≤20 years) was not considered.
Childhood polyarteritis nodosa
Step 1: Web-based data collection A total of 172/1398 (12%) children with c-PAN were available in the database.
Step 2: Classifi cation of diffi cult cases by consensus panel Sixty patients (37 diffi cult cases and 23 randomly selected) were blinded for the referring centre diagnosis and classifi ed by the consensus panel: 38 as c-PAN while 22 were excluded (more than one reason possible: one because of hepatitis B association, two because of incomplete data, 12 because consensus was not achieved and 10 because they were unclassifi able). The κ-agreement between the consensus panel and treating physician was 0.73 (95% CI 0.62 to 0.84), therefore justifying the inclusion of all 150 patients with c-PAN into the next step. The group.bmj.com on March 13, 2012 -Published by ard.bmj.com Downloaded from and 16 (11%) with deep skin infarction. Hypertension was documented in 44 (29%) patients with c-PAN and in 55 (63%) with c-TA. Peripheral neuropathy (mono-or polyneuropathy) in 39 (26%) and renal involvement (proteinuria, haematuria or red blood cell casts) in 44 (29%). Finally, testicular pain or tenderness was present in 15/75 male children (20%) and signs/ symptoms suggesting vasculitis of any other major organ system (pulmonary, gastrointestinal, cardiovascular, or central nervous system) were reported in 113 (75%). There were no other signs and symptoms that were more frequently observed in patients with c-PAN than in the other vasculitides (see accompanying paper 9 for further details and online supplementary fi gure 1B). Figure 1B shows the sensitivities/specifi cities of patients with c-PAN versus the other c-vasculitides. Specifi city was >99.5% for the mandatory criteria with sensitivity being higher for aneurysm (72%), followed by medium-, small-size artery necrotising vasculitis and stenoses. Sensitivity/specifi city for histopathological changes or angiographic abnormalities combined were 90.6%/99.6% in this population. Specifi city of the remaining signs/symptoms were>80% with the exception of renal involvement (37%), while sensitivity was >70% only for skin involvement and myalgia. Table 2 provides a glossary of defi nitions, sensitivity/specifi city/AUC for each c-PAN criterion and the fi nal EULAR/ PRINTO/PRES defi nition. The sensitivities/specifi cities/AUC and κ-agreement (between the consensus panel and specifi c defi nition) of the fi nal EULAR/PRINTO/PRES c-PAN classifi cation defi nition was 89.6%/99.6%/94.6%, respectively, with an almost perfect κ-agreement of 0.92 (95% CI 0.86 to 0.98) compared with 86.3%/99.6%/93% of the preliminary EULAR c-PAN proposal. The sensitivity/specifi city for the original adult PAN ACR criteria were 94.7%/95.2%/95% (κ=0.77) in this paediatric population.
Childhood Wegener granulomatosis
Step 1: Web-based data collection A total 0f 67/1398 (5%) children with c-WG were available in the database.
Step 2: Classifi cation of diffi cult cases by consensus panel Sixty patients (19 diffi cult cases and 41 randomly selected) were blinded for the referring centre diagnosis and classifi ed by the consensus panel: 51 were confi rmed as c-WG (plus one was originally diagnosed as c-PAN and one as another form of c-vasculitis) while nine were excluded (multiple reasons possible: one because age at onset >18 years, one because of other co-morbid conditions, fi ve because consensus was not achieved and four because they were classifi ed as c-other). The κ-agreement between consensus panel and treating physician was 0.88 (95% CI 0.76 to 0.99), therefore justifying the inclusion of all 60 patients with c-WG in the next step.
Step 3: Statistical and consensus evaluations The 60/1183 (5%) patients with c-WG (seven diagnosed by the treating physician and 53 by the consensus panel) were included in the fi nal analysis and compared with the remaining 1123 patients (HSP 827, c-PAN 150, c-TA 87, c-other 59 patients).
Granulomatous infl ammation lesions were present in 27/50 patients (54%) (13 in the upper airways, seven kidney, four orbital mass, three others). More than 70% of the patients had upper airway involvement (either nasal discharge or septum perforation or sinus infl ammation), chest x-ray or CT signs (47/60 patients, 78%), versus <10% in the other vasculitides. Immunofl uorescence antineutrophilic cytoplasmic antibody (ANCA) was positive in 47 (78%) patients, MPO/pANCA in 14 (23%) and PR3/cANCA in 38 (63%) (any ANCA positivity in 54, 90%) while the frequency of any ANCA positivity was 11% in c-PAN and <5% in the other vasculitides. Renal involvement was observed in 39 (65%) of the patients with 24 (40%) patients having necrotising pauci-immune glomerulonephritis. There were no other signs and symptoms, laboratory/ biopsy/imaging reports that were more frequently observed in patients with c-WG than in the other vasculitides (see accompanying paper 9 for further details and online supplementary fi gure 2A). Figure 2A shows the sensitivities/specifi cities of patients with c-WG versus the other c-vasculitides. Sensitivities/specifi cities were >75% for upper airway involvement, pulmonary 
involvement on chest x-ray or CT and ANCA (sensitivities/ specifi cities immunofl uorescence 84%/91%, MPO 26%/94%, PR3 69%/96%). Table 3 provides the glossary of defi nitions, sensitivity/ specifi city/AUC for each c-WG criterion and the fi nal EULAR/ PRINTO/PRES defi nition. The sensitivities/specifi cities of the fi nal 2009 EULAR/PRINTO/PRES classifi cation defi nition were 93.3%/99.2%/96.3%, respectively, with an almost perfect κ-agreement of 0.90 (95% CI 0.84 to 0.97) compared with 88%/100%/94% for the preliminary EULAR c-WG proposal. The sensitivities/specifi cities of the original adult WG ACR criteria were 83%/98%/90.5% (κ=0.77) in this paediatric population.
Childhood Takayasu arteritis
Step 1: Web-based data collection A total of 99/1398 (7%) children with c-TA were available in the database.
Step 2: Classifi cation of diffi cult cases by consensus panel Sixty patients (10 diffi cult cases and 50 randomly selected) were blinded for the referring centre diagnosis and classifi ed by the consensus panel: 48 as c-TA while 12 were excluded (multiple reasons possible: two because age at onset was >18 years, one because of incomplete data, nine because consensus was not achieved and three because they were unclassifi able). The κ-agreement between consensus panel and treating physician was 0.84 (95% CI 0.73 to 0.96) therefore justifying the inclusion of all 87 patients with c-TA in the next step.
Step 3: Statistical and consensus evaluations The 87/1183 (7%) patients with c-TA (39 diagnosed by the treating physician and 48 by the consensus panel) were included in the fi nal analysis and compared with the remaining 1096 patients with other form of vasculitides (HSP 827, c-PAN 150, c-WG 60, other forms 59 patients).
All 87 patients had angiographic abnormalities (100%) (for three patients stenoses were documented by MRI or CT), of whom 74 (85%) had stenoses and 43 (49%) aneurysms. Decreased peripheral artery pulse(s) were observed in 62 (71%) and claudication of extremities in 33 (38%) (either signs in 65 patients, 75%). Discrepancy of four limb BP >10 mm Hg, bruits over aorta and/ or its major branches were reported in 54 (62%) and 50 (57%) patients, respectively. Also, hypertension was present in 55 (63%) children as compared with the 44 (29%) patients with c-PAN and six (10%) with WG. Abnormal acute phase reactants (erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP)) were observed, at the time of diagnosis, in 76 (87%), similar to c-PAN and c-WG. There were no other signs and symptoms that were more frequently observed in patients with c-TA than in the other vasculitides (see accompanying paper 9 for further details and online supplementary fi gure 2B). Figure 2B shows the sensitivities/specifi cities of patients with c-TA versus the other c-vasculitides. Stenoses had higher sensitivities/specifi cities (85%/100%) than aneurysms (49%/99.9%) (stenoses or aneurysm 100%/99.9%). The other four features showed a specifi city of ≥90%, while sensitivity was >70% only for pulse defi cit/claudication. Sensitivities/specifi cities of abnormal acute phase reactants (ESR<20 or CRP elevated) were 95%/14%. Table 4 provides a glossary of defi nitions, sensitivity/specifi city/AUC for each c-TA criterion and the fi nal EULAR/ PRINTO/PRES defi nition. The sensitivity/specifi city/AUC of the fi nal EULAR/PRINTO/PRES classifi cation defi nition was 100%/99.9%/99.95%, respectively, with an almost perfect κ-agreement of 0.99 (95% CI 0.93 to 1) compared with 94.3%/99.9%/97.1% of the preliminary EULAR c-TA proposal. The sensitivities/specifi cities for the original adult TA ACR criteria were 85.1%/99.6%/92.4% (κ=0.89) in this paediatric population with a decrease in sensitivity if the age criterion (<40 years) was removed.
Further results on sensitivities, specifi cities, AUC and κ-agreement
In order to control for potential skewing of data we repeated the analysis with a random sample of 120 patients with HPS instead of the full 827 sample. Sensitivities, specifi cities, AUC and κ-agreement of the fi nal classifi cation criteria, as well as of the individual criterion for HSP, c-PAN, c-WG and c-TA did not change when a random sample of 120 patients with HSP was used instead of the full 827 HSP sample (data not shown).
DISCUSSION
The diagnosis of classic HSP is commonly made by paediatricians. However, validated classifi cation criteria did not exist. This is crucial for future collaborative studies, which require standardised criteria. While there are some similarities between the original ACR criteria and the new criteria (eg, purpura and abdominal pain), some changes were also considered. The ACR criteria required biopsy showing granulocytes in the walls of arterioles or venules; however, this criterion had a very low 
on the borders of cutaneous PAN, which constitutes a large group in paediatric practice. 13 We have not included in the analysis microscopic polyangiitis and cutaneous c-PAN since data related to these two subgroups of the disease were few and since they were empirically defi ned in the 2005 EULAR/ PRES criteria.
For c-WG the main differences from the ACR criteria were the addition of chest CT scan results, the inclusion of ANCA positivity and more specifi c items for upper and lower respiratory involvement. These additions were thought to be important since c-WG has some features such as more frequent subglottic stenoses that differentiate it from the adult form. 14 Very minor changes were made to the original 2005 EULAR/PRES c-WG that includes any detected ANCA (immunofl uorescence/MPO/ PR3) as a positive fi nding. Thus, the fi nal EULAR/PRINTO/PRES defi nition had a slight increase in specifi city compared with the preliminary 2005 EULAR-endorsed c-WG criteria. 7 Also, the sensitivity/specifi city of the fi nal defi nition was higher than the original ACR criteria as also reported recently by Cabral et al 15 who used, as control group, other ANCA-associated vasculitides. At the Ankara Consensus Conference limited forms of c-WG, such as isolated orbital/retro-orbital disease or limited upper airway involvement, were specifi cally considered and it was agreed they should be dealt with in the future separately from the more widespread form of the disease. Similarly, it was not possible to formally differentiate c-WG from microscopic polyangiitis and Churg-Strauss syndrome since too few cases were available in the dataset. Thus, at present, the approach suggested by Watts et al 16 to differentiate between WG and microscopic polyangiitis could be applied to children since the surrogate markers described in his classifi cation algorithm are also included in their classifi cation.
For c-TA, angiographic fi ndings are crucial in the diagnosis and thus this criterion had already been defi ned as mandatory in the 2005 EULAR/PRES 7 c-TA criteria. We had also considered more recent imaging modalities, such as CT or MRI, which were not considered at the time the ACR criteria were published. Indeed, arteriographic abnormalities were present specifi city in this paediatric population. On the other hand, although biopsies were rarely done, the presence of IgA in the biopsy was very specifi c. Thus the consensus panel chose histopathology showing typically leucocytoclastic vasculitis with predominant IgA deposit or proliferative glomerulonephritis with predominant IgA deposit for all doubtful cases such as for purpura with atypical characteristics or distribution. Other differences were related to the inclusion of joint involvement that is more common and with higher sensitivity in children than in the patients of the ACR paper. 1 Renal involvement was also considered worth including to underline the importance of prospective monitoring for haematuria/proteinuria when HSP evolves to severe renal damage. The fi nal HSP defi nition had greater sensitivity than the preliminary 2005 EULAR-endorsed criteria, 7 with a substantial κ-agreement with the blinded evaluation of diffi cult cases by the consensus panel. Although the sensitivity and specifi city of the ACR was >87% in the subjects analysed in the original paper, 1 the specifi city dropped dramatically in our sample because all patients had, by inclusion criteria, an age <18 years; indeed, the specifi city rose to 75% when the age criterion was removed.
For the diagnosis of c-PAN, histopathological and angiographic fi ndings are crucial and for this reason this combined criterion was already mandatory in the 2005 EULAR/PRES 7 criteria. During the discussion there was a specifi c concern about the imaging modalities to be used in children owing to the recent advances in these techniques. Although conventional angiogram remains the current 'gold standard', it is an invasive technique especially in young children where the problem of radiation should also be considered. The group is aware that imaging modalities are advancing rapidly. Future studies may establish a place for non-invasive angiographic techniques. The major change to the original 2005 EULAR/PRES-endorsed c-PAN criteria was the removal of the criteria for the signs and symptoms for vasculitis in specifi c organ systems and testicular pain or tendernes; this change led to an increase of the sensitivity and to a simplifi cation of the fi nal criteria. A special challenge in the classifi cation of PAN is the lack of consensus in 41% of the children and this fi gure rose to 100% when we considered all imaging modalities. During the consensus discussion special emphasis was placed on the differential diagnosis of non-infl ammatory conditions such as fi bromuscular dysplasia or mid-aortic syndrome for which future imaging technologies may be of help. Other differences from the ACR were the combination of pulse defi cit and claudication, which were both very frequent (75%) and highly specifi c, the addition of hypertension (more frequent than in the other c-vasculitides) and the removal of the age limit criterion. Moreover, the addition of increased acute phase reactants as an extra criterion, led us to properly classify all cases in which this laboratory sign, associated with angiographic abnormalities, was an important fi nding before the onset of complications such as hypertension or pulse deficit or claudication. Together, these changes increased the sensitivity to 100% and the κ-agreement reached between the fi nal classifi cation defi nition and the consensus panel choice was very close to 1. It should be noted that in children, TA is a distinct and unique entity while by contrast in adult disease, relatively younger patients with giant cell arteritis and relatively older patients with TA may cause some diffi culty in classifi cation. The main advantage of the proposed defi nitions lies in the worldwide data collection that ensures greater variability of the cases examined, as well as in full validation testing that combined both statistics and consensus formation processes. The fi nal EULAR/PRINTO/PRES criteria had an overall better performance for all four diseases, with substantially better specifi city for defi ning the disease. They also all reached a κ-agreement of >0.80 between the fi nal classifi cation defi nition and the consensus panel. Thus we suggest that, at least in children, they are superior to the previously existing criteria. With these new validated classifi cation criteria we can start planning multicentre studies similar to those carried out by EUVAS, and gathering our expertise and knowledge so that we can serve these children better. It should be emphasised, however, that the proposed defi nitions are not diagnostic criteria but rather classifi cation criteria.
In conclusion EULAR/PRINTO/PRES propose validated classifi cation criteria for HSP, c-PAN, c-WG and c-TA with high sensitivity/specifi city. 
